Investigation of the prognostic factor of the sarcoidosis by using the analysis of intrapulmonary microbiome.

Investigation of the prognostic factor of the sarcoidosis by using the analysis of intrapulmonary microbiome. - Prognostic factor of the sarcoidosis based on microbiome analysis.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025081

Enrollment

100

Registered

2016-11-30

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcoidosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with sarcoidosis

Exclusion criteria

Exclusion criteria: The patients who cannot undergo bronchoalveolar lavage. The patients with the serious respiratory disorder. A pregnant woman and the patients who may be pregnant.

Design outcomes

Primary

Measure	Time frame
Intrapulmonary microbiome at diagnosis, and reduction ratio of the mediastinal hilar lymph node during three years.	—

Countries

Japan

Contacts

Public ContactHiroshi Ishimoto

Nagasaki university hospital Respiratory medicine

h-ishimoto@nagasaki-u.ac.jp095-819-7273

Outcome results